Addressing Antimicrobial Resistance in Nepal: A Call for Collaborative Efforts

Authors

  • Sitaram Khadka Shree Birendra Hospital; Nepalese Army Institute of Health Sciences, Kathmandu, Nepal
  • Santoshi Giri Nepal Public Health Research and Development Center, Kathmandu, Nepal

Keywords:

Antimicrobial Resistance, AMR

Abstract

Being one of the most important discoveries of medical sciences, antibiotics are, no doubt, considered life-saving drugs. However, antimicrobial resistance (AMR) intimidates the advancement in medical science posing a substantial risk to lives. Currently, around 700,000 people die each year due to drug-resistant diseases that might reach up to 10 million deaths annually by 2050 if remain
unchecked.2 It is also estimated that by 2030, AMR would force about 24 million people into extreme poverty. AMR is no longer a concern for the distant future but is a global pressing issue that requires immediate attention.3 WHO has declared AMR as one of the top 10 global public health threats facing humanity. AMR has been increasing alarmingly globally. Most bacterial pathogens have shown high resistance to the majority of first- and some second-line antibiotics.5 The Global Antimicrobial Resistance
and Use Surveillance System (GLASS) report 2019 reported that Escherichia coli and Klebsiella pneumoniae causing UTIs showed 54.4% and 43.1% resistance to the first-line antibiotic cotrimoxazole and 43.1% and 36.4% for ciprofloxacin, the 2nd option drug respectively.

Downloads

Download data is not yet available.
Abstract
0
Download Full Text PDF
0

Downloads

Published

2025-04-05

How to Cite

Khadka, S. ., & Giri, S. . (2025). Addressing Antimicrobial Resistance in Nepal: A Call for Collaborative Efforts. Europasian Journal of Medical Sciences, 5(2). Retrieved from https://nepjol.info./index.php/ejms/article/view/49077

Issue

Vol. 5 No. 2 (2021): Europasian Journal of Medical Sciences (EJMS) | 2021 (July - December) Issue 6

Section

Editorial

License

Copyright (c) 2025 Sitaram Khadka, Santoshi Giri

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The author(s) retain the ownership of the copyrights for their work published in EJMS without any restrictions. Upon submission, the author(s) grants EJMS a license to publish, including to display, store, copy, and reuse the published content.

License to Publish
By submitting a manuscript to EJMS, the author(s) grant the journal a non-exclusive license to:

  • Publish and distribute the content in all formats, media, and platforms (both existing and future), while identifying EJMS as the original publisher.
  • Reproduce, display, and store the content in both print and online formats, including institutional and digital repositories.
  • Translate, adapt, and summarize the work, including reprints, extracts, and abstracts.
  • Develop derivative works based on the original content.
  • Include the work in electronic databases and provide links to third-party materials.

Creative Commons Licensing
In addition to EJMS’s publishing rights, authors grant third parties the right to use, share, and distribute their work under the Creative Commons Attribution 4.0 (CC BY 4.0) International License. This allows unrestricted use of the content, provided proper attribution is given to the original author(s) and the journal.